Oral Pimonidazole HCl as Tumor Hypoxia Marker: Report of First Clinical Use - Pharmacokinetics and Tolerance
Saved in:
Published in: | International journal of radiation oncology, biology, physics Vol. 75; no. 3; pp. S539 - S540 |
---|---|
Main Authors: | , , |
Format: | Journal Article |
Language: | English |
Published: |
Elsevier Inc
2009
|
Subjects: | |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Author | Raleigh, J.A Varia, M.A Lee, D.Y.W |
---|---|
Author_xml | – sequence: 1 fullname: Varia, M.A – sequence: 2 fullname: Lee, D.Y.W – sequence: 3 fullname: Raleigh, J.A |
BookMark | eNqFkU1LAzEQhoMo2FZ_gpA_sOtks58eFCnWCpUWbcFbSJNZzHZ3U5JWrL_eXdqTF09zmfdh3meG5Ly1LRJywyBkwNLbKjSVs-ttGAEUIWQhi3h0RgYsz4qAJ8nHORkATyHg3fYlGXpfAQBjWTwg9dzJmi5MY1uj5Y-tkU7HNZWeLveNdXR62NpvI-mrdBt0d_QNt9btqC3pxDi_o-PatEZ1iJVHGtDFp3SNVHZjWtwZ5alsNV12VCdbhVfkopS1x-vTHJHV5Gk5ngaz-fPL-HEWKJZkUSAlZnEap6jylGeM6wJYWTJIc60TqZJijZp33RLGJEgFcar0uoiLknO1LlnORyQ5cpWz3jssxdaZRrqDYCB6ZaISR2WiVyYgE72yLvdwzGF33JdBJ7wy2B2ujUO1E9qafwn3fwjqJGiDB_SV3bu2ay6Y8JEA8d6_pf8KFBBFWcz5L9xYjh4 |
ContentType | Journal Article |
Copyright | Elsevier Inc. 2009 Elsevier Inc. |
Copyright_xml | – notice: Elsevier Inc. – notice: 2009 Elsevier Inc. |
DBID | AAYXX CITATION |
DOI | 10.1016/j.ijrobp.2009.07.1232 |
DatabaseName | CrossRef |
DatabaseTitle | CrossRef |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1879-355X |
EndPage | S540 |
ExternalDocumentID | 10_1016_j_ijrobp_2009_07_1232 S0360301609022743 1_s2_0_S0360301609022743 |
GroupedDBID | --- --K .1- .55 .FO .GJ 0R~ 1B1 1P~ 1RT 1~5 29J 4.4 457 4G. 53G 5RE 5VS 7-5 AAEDT AAEDW AALRI AAQFI AAQQT AAQXK AAWTL AAXUO ABEFU ABJNI ABLJU ABNEU ABOCM ABUDA ACGFS ACIUM ADBBV ADMUD ADPAM ADVLN AENEX AEVXI AFCTW AFFNX AFJKZ AFRHN AFTJW AGRDE AHHHB AITUG AJUYK AKRWK ALMA_UNASSIGNED_HOLDINGS AMRAJ ASPBG AVWKF AZFZN BELOY DU5 EBS EFJIC EJD F5P FDB FEDTE FGOYB FIRID G-2 GBLVA HED HMK HMO HVGLF HX~ HZ~ IHE J1W KOM LX3 M41 MO0 NQ- O9- OC~ OO- R2- RIG RNS ROL RPZ SAE SDG SEL SES SEW SSZ UDS UV1 X7M XH2 XPP Z5R ZGI ~S- AAIAV AGZHU AHPSJ ALXNB ZA5 AAYXX CITATION |
ID | FETCH-LOGICAL-c1572-aae74646ec863713d901ff1068dd5ac59bed3879511a0ac046cdb949f33cbf183 |
ISSN | 0360-3016 |
IngestDate | Thu Sep 26 19:30:09 EDT 2024 Fri Feb 23 02:25:33 EST 2024 Tue Oct 15 22:55:28 EDT 2024 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 3 |
Language | English |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c1572-aae74646ec863713d901ff1068dd5ac59bed3879511a0ac046cdb949f33cbf183 |
ParticipantIDs | crossref_primary_10_1016_j_ijrobp_2009_07_1232 elsevier_sciencedirect_doi_10_1016_j_ijrobp_2009_07_1232 elsevier_clinicalkeyesjournals_1_s2_0_S0360301609022743 |
PublicationCentury | 2000 |
PublicationDate | 2009 |
PublicationDateYYYYMMDD | 2009-01-01 |
PublicationDate_xml | – year: 2009 text: 2009 |
PublicationDecade | 2000 |
PublicationTitle | International journal of radiation oncology, biology, physics |
PublicationYear | 2009 |
Publisher | Elsevier Inc |
Publisher_xml | – name: Elsevier Inc |
SSID | ssj0001174 |
Score | 1.9474957 |
SourceID | crossref elsevier |
SourceType | Aggregation Database Publisher |
StartPage | S539 |
SubjectTerms | Hematology, Oncology and Palliative Medicine Radiology |
Title | Oral Pimonidazole HCl as Tumor Hypoxia Marker: Report of First Clinical Use - Pharmacokinetics and Tolerance |
URI | https://www.clinicalkey.es/playcontent/1-s2.0-S0360301609022743 https://dx.doi.org/10.1016/j.ijrobp.2009.07.1232 |
Volume | 75 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9NAEF6lRUJcEE8RXtoDt8jG67e5VWmqXApVk0LhstqXpYQSVzaRgF_PrPfh0FYIkLhY0cqv7HzZ-XYy8w1Cr8qIq5TUVcCUUEGq82g4y3gQ50LkUSVJ3JeLzRfF2_PycJbORiPXE28Y-6-WhjGwta6c_Qtr-5vCAHwGm8MRrA7HP7L7O11xfwIW2Kwk-6FzB-fTC91NZrn90rST-ffL5tuK9TU6qjXpcJqCa9J4tAIqOJm6WsmzTk2CyYnVtv4MdNRLOi_hvq3Hy3rIhh-CizuSFK3WPzDMdCN8dQwfCmVMeMWz-_ewf-857XF4EF7JGDoMP4Yf_OAp60O7PRTduS6EMSyRvqrml6RPcKrgGyJiJbLNwlwWVQDc6Hx35TY9VyxCk51leJEZhSTr0heZkYS65i5M5GIdrtZtw516aRFqmjn4R5-1uNAvpt9L57LCbj7ZQ7diWN90y4ZP2aknAMSKf7uvMRSOvb7xUTdToh2as7yH7tr9CT4wwLqPRmrzAN0-thkYD9GFxhfexRcGfGHW4R5f2OILG3y9wQZduKlxjy7s0IUBXTjAV9GFAV3Yo-sROjuaLafzwHbsCATJijhgTBVpnuZKlHlSkEQC26xrEuWllBkTWcWVTHR7e0JYxESU5kLyKq3qJBG8Bu_yGO1vmo16gjDsRLTUXSUknBapmHNZSK6qGjYYJI7SMQrdpNFLI8xCXcbimppZ1j1WKxoVVM_yGBVuaqmrOgY_qTr7e-gooV1MI3rNzGNU-istLzV8kwKOfv_Qp_9-6TN0x_xzqcN9z9H-13arXqC9Tm5f9nD7CbAEsJg |
link.rule.ids | 315,782,786,4030,27934,27935,27936 |
linkProvider | Elsevier |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Oral+Pimonidazole+HCl+as+Tumor+Hypoxia+Marker%3A+Report+of+First+Clinical+Use+-+Pharmacokinetics+and+Tolerance&rft.jtitle=International+journal+of+radiation+oncology%2C+biology%2C+physics&rft.au=Varia%2C+M.A.&rft.au=Lee%2C+D.Y.W.&rft.au=Raleigh%2C+J.A.&rft.date=2009&rft.pub=Elsevier+Inc&rft.issn=0360-3016&rft.eissn=1879-355X&rft.volume=75&rft.issue=3&rft.spage=S539&rft.epage=S540&rft_id=info:doi/10.1016%2Fj.ijrobp.2009.07.1232&rft.externalDocID=S0360301609022743 |
thumbnail_m | http://sdu.summon.serialssolutions.com/2.0.0/image/custom?url=https%3A%2F%2Fcdn.clinicalkey.com%2Fck-thumbnails%2F03603016%2FS0360301609X00155%2Fcov150h.gif |